Literature DB >> 15902687

Regulation of the Leishmania-induced innate inflammatory response by the protein tyrosine phosphatase SHP-1.

Geneviève Forget1, Claudine Matte, Katherine A Siminovitch, Serge Rivest, Philippe Pouliot, Martin Olivier.   

Abstract

Modulation of the phagocyte protein tyrosine phosphatase (PTP) SHP-1 by the parasite Leishmania favors its survival and propagation within its mammalian host. In vivo, the absence of SHP-1 leads to virtually absent footpad swelling, accompanied by enhanced inducible nitric oxide synthase expression. In this study, using an air pouch model, we show that viable motheaten SHP-1-deficient mice harbored a stronger inflammatory response against Leishmania infection than wild-type mice. This response was portrayed by higher pro-inflammatory cytokine (TNF-alpha, IL-1beta and IL-6) expression and secretion and by greater chemokine and chemokine receptor expression. These inflammatory molecules were probably responsible for the stronger cellular recruitment, mainly of neutrophils, seen at the site of infection in viable motheaten mice within 6 h post inoculation. We also provide strong evidence that protein tyrosine phosphatases in general, and SHP-1 in particular, are important regulators of chemokine gene expression. Overall, this study suggests that the ability of Leishmania to induce SHP-1 activity in its host allows the taming of an otherwise strong innate inflammatory response that would be detrimental for its survival and progression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15902687     DOI: 10.1002/eji.200526037

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  28 in total

Review 1.  The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury.

Authors:  Z Z Chong; K Maiese
Journal:  Histol Histopathol       Date:  2007-11       Impact factor: 2.303

2.  Host-pathogen interaction: Culprit within a culprit.

Authors:  Martin Olivier
Journal:  Nature       Date:  2011-03-10       Impact factor: 49.962

Review 3.  Shp1 function in myeloid cells.

Authors:  Clare L Abram; Clifford A Lowell
Journal:  J Leukoc Biol       Date:  2017-06-12       Impact factor: 4.962

4.  Comparative study of the ability of Leishmania mexicana promastigotes and amastigotes to alter macrophage signaling and functions.

Authors:  Issa Abu-Dayyeh; Kasra Hassani; Edze R Westra; Jeremy C Mottram; Martin Olivier
Journal:  Infect Immun       Date:  2010-04-05       Impact factor: 3.441

5.  Central neuroinvasion and demyelination by inflammatory macrophages after peripheral virus infection is controlled by SHP-1.

Authors:  George P Christophi; Paul T Massa
Journal:  Viral Immunol       Date:  2009-12       Impact factor: 2.257

6.  Modulation of macrophage infiltration and inflammatory activity by the phosphatase SHP-1 in virus-induced demyelinating disease.

Authors:  George P Christophi; Chad A Hudson; Michael Panos; Ross C Gruber; Paul T Massa
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

7.  Mitogen-activated protein kinases and NFkappaB are involved in SP-A-enhanced responses of macrophages to mycobacteria.

Authors:  Joseph P Lopez; David J Vigerust; Virginia L Shepherd
Journal:  Respir Res       Date:  2009-07-01

8.  Inhibition of the human neutrophil NADPH oxidase by Coxiella burnetii.

Authors:  Daniel W Siemsen; Liliya N Kirpotina; Mark A Jutila; Mark T Quinn
Journal:  Microbes Infect       Date:  2009-04-18       Impact factor: 2.700

Review 9.  Dysregulation of macrophage signal transduction by Toxoplasma gondii: past progress and recent advances.

Authors:  J Leng; B A Butcher; E Y Denkers
Journal:  Parasite Immunol       Date:  2009-12       Impact factor: 2.280

10.  Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype.

Authors:  George P Christophi; Michael Panos; Chad A Hudson; Rebecca L Christophi; Ross C Gruber; Akos T Mersich; Scott D Blystone; Burk Jubelt; Paul T Massa
Journal:  Lab Invest       Date:  2009-04-27       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.